- Home
- CASI vs TURN Comparison
CASI vs TURN Comparison
Compare CASI & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- TURN
- Stock Information
- Founded
- CASI 1991
- TURN 1981
- Country
- CASI China
- TURN United States
- Employees
- CASI N/A
- TURN 8
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- CASI Health Care
- TURN Finance
- Exchange
- CASI Nasdaq
- TURN Nasdaq
- Market Cap
- CASI 33.4M
- TURN 35.3M
- IPO Year
- CASI 1996
- TURN N/A
- Fundamental
- Price
- CASI $1.94
- TURN $3.83
- Analyst Decision
- CASI Strong Buy
- TURN
- Analyst Count
- CASI 1
- TURN 0
- Target Price
- CASI $4.00
- TURN N/A
- AVG Volume (30 Days)
- CASI 13.6K
- TURN 49.8K
- Earning Date
- CASI 05-13-2025
- TURN 05-12-2025
- Dividend Yield
- CASI N/A
- TURN N/A
- EPS Growth
- CASI N/A
- TURN N/A
- EPS
- CASI N/A
- TURN N/A
- Revenue
- CASI $28,537,000.00
- TURN $194,813.00
- Revenue This Year
- CASI $66.12
- TURN N/A
- Revenue Next Year
- CASI $51.37
- TURN N/A
- P/E Ratio
- CASI N/A
- TURN N/A
- Revenue Growth
- CASI N/A
- TURN 254.25
- 52 Week Low
- CASI $1.88
- TURN $3.12
- 52 Week High
- CASI $7.67
- TURN $4.20
- Technical
- Relative Strength Index (RSI)
- CASI 41.12
- TURN 53.62
- Support Level
- CASI $1.91
- TURN $3.41
- Resistance Level
- CASI $2.14
- TURN $3.94
- Average True Range (ATR)
- CASI 0.20
- TURN 0.29
- MACD
- CASI -0.01
- TURN 0.01
- Stochastic Oscillator
- CASI 11.11
- TURN 80.00
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.